1. Home
  2. LVS vs ZTS Comparison

LVS vs ZTS Comparison

Compare LVS & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Las Vegas Sands Corp.

LVS

Las Vegas Sands Corp.

HOLD

Current Price

$44.53

Market Cap

31.2B

ML Signal

HOLD

Logo Zoetis Inc.

ZTS

Zoetis Inc.

SELL

Current Price

$75.50

Market Cap

32.5B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
LVS
ZTS
Founded
1988
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.2B
32.5B
IPO Year
2004
2012

Fundamental Metrics

Financial Performance
Metric
LVS
ZTS
Price
$44.53
$75.50
Analyst Decision
Buy
Buy
Analyst Count
14
12
Target Price
$69.21
$154.18
AVG Volume (30 Days)
4.1M
4.8M
Earning Date
04-22-2026
05-07-2026
Dividend Yield
2.23%
1.86%
EPS Growth
19.90
10.05
EPS
1.38
3.08
Revenue
$13,017,000,000.00
$9,467,000,000.00
Revenue This Year
$7.24
$5.63
Revenue Next Year
$4.49
$4.77
P/E Ratio
$32.32
$24.82
Revenue Growth
15.22
2.28
52 Week Low
$43.36
$71.00
52 Week High
$70.45
$149.75

Technical Indicators

Market Signals
Indicator
LVS
ZTS
Relative Strength Index (RSI) 42.91 50.81
Support Level $44.58 $73.02
Resistance Level $54.81 $78.74
Average True Range (ATR) 1.23 2.21
MACD -0.16 0.14
Stochastic Oscillator 29.87 70.32

Price Performance

Historical Comparison
LVS
ZTS

About LVS Las Vegas Sands Corp.

Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner Macao, Four Seasons Hotel Macao, and Parisian Macao, as well as the Marina Bay Sands resort in Singapore. We expect Sands to open a fourth tower in Singapore in 2031. Its Venetian and Palazzo Las Vegas assets in the US were sold to Apollo and Vici in 2022. After the sale of its Vegas assets, Sands generates all its EBITDA from Asia, with its casino operations generating the majority of sales.

About ZTS Zoetis Inc.

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Share on Social Networks: